Recently, it was reported that biallelic alterations of TP53 led to complex chromosome abnormalities and rapid progression in myelodysplastic neoplasms, which was defined as a unique subtype in the WHO classification23. This evidence concerns the gene TP53 and myelodysplastic syndrome.